Limited and localized outbreak of newly emergent type 2 vaccine-derived poliovirus in Sichuan, China

Clinical and Vaccine Immunology

Volumn 21, Issue 7, 2014, Pages 1012-1018

  Yan, Dongmei ^a   Zhang, Yong ^a   Zhu, Shuangli ^a   Chen, Na ^b   Li, Xiaolei ^a   Wang, Dongyan ^a   Ma, Xiaozhen ^b   Zhu, Hui ^a   Tong, Wenbin ^b   Xu, Wenbo ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b Sichuan Center for Disease Control and Prevention   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; ORAL POLIOMYELITIS VACCINE; VP1 PROTEIN, POLIOVIRUS;

CHINA; EPIDEMIC; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; INFANT; MALE; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOGENICITY; POLIOMYELITIS; POLIOMYELITIS VIRUS; SEQUENCE ANALYSIS; TRANSMISSION;

BASE SEQUENCE; CAPSID PROTEINS; CHINA; DISEASE OUTBREAKS; FEMALE; HUMANS; INFANT; MALE; MOLECULAR SEQUENCE DATA; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL; SEQUENCE ANALYSIS, RNA;

EID: 84904467580     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00196-14     Document Type: Article

References (36)

1. Centers for Disease Control and Prevention. 2001. Apparent global interruption of wild poliovirus type 2 transmission. MMWR Morb. Mortal. Wkly. Rep. 50:222-224.
2. Kew OM, Sutter RW, de Gourville EM, Dowdle WR, Pallansch MA. 2005. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu. Rev. Microbiol. 59:587-635. http://dx.doi.org/10.1146/ annurev.micro.58.030603.123625. (Pubitemid 41507443)
3. Kew OM, Wright PF, Agol VI, Delpeyroux F, Shimizu H, Nathanson N, Pallansch MA. 2004. Circulating vaccine-derived polioviruses: current state of knowledge. Bull. World Health Organ. 82:16-23. (Pubitemid 38220338)
4. Jorba J, Campagnoli R, De L, Kew O. 2008. Calibration of multiple poliovirus molecular clocks covering an extended evolutionary range. J. Virol. 82:4429-4440. http://dx.doi.org/10.1128/JVI.02354-07. (Pubitemid 351563679)
5. Kew OM, Sutter RW, Nottay BK, McDonough MJ, Prevots DR, Quick L, Pallansch MA. 1998. Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient. J. Clin. Microbiol. 36:2893-2899. (Pubitemid 28429411)
6. Bellmunt A, May G, Zell R, Pring-Akerblom P, Verhagen W, Heim A. 1999. Evolution of poliovirus type I during 5.5 years of prolonged enteral replication in an immunodeficient patient. Virology 265:178-184. http://dx.doi.org/10.1006/ viro.1999.0003. (Pubitemid 30022213)
7. Zhang Y, Yan D, Zhu S, Wen N, Li L, Wang H, Liu J, Ye X, Ding Z, Wang D, Zhu H, Chen L, Hou X, An H, Liang X, Luo H, Kew O, Xu W. 2010. Type 2 vaccine-derived poliovirus from patients with acute flaccid paralysis in China: current immunization strategy effectively prevented its sustained transmission. J. Infect. Dis. 202:1780-1788. http://dx.doi.org/10.1086/657410.
8. Fine PE, Carneiro IA. 1999. Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative. Am. J. Epidemiol. 150:1001-1021. http://dx.doi.org/10.1093/ oxfordjournals.aje.a009924. (Pubitemid 29531936)
9. Burns CC, Shaw J, Jorba J, Bukbuk D, Adu F, Gumede N, Pate MA, Abanida EA, Gasasira A, Iber J, Chen Q, Vincent A, Chenoweth P, Henderson E, Wannemuehler K, Naeem A, Umami RN, Nishimura Y, Shimizu H, Baba M, Adeniji A, Williams AJ, Kilpatrick DR, Oberste MS, Wassilak SG, Tomori O, Pallansch MA, Kew O. 2013. Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria. J. Virol. 87:4907-4922. http://dx.doi.org/10.1128/JVI.02954-12.
10. Dowdle WR, De Gourville E, Kew OM, Pallansch MA, Wood DJ. 2003. Polio eradication: the OPV paradox. Rev. Med. Virol. 13:277-291. http://dx.doi.org/10. 1002/rmv.401. (Pubitemid 37082191)
11. Chen RT, Hausinger S, Dajani AS, Hanfling M, Baughman AL, Pallansch MA, Patriarca PA. 1996. Seroprevalence of antibody against poliovirus in inner-city preschool children. Implications for vaccination policy in the United States. JAMA 275:1639-1645. (Pubitemid 26175810)
12. Kilpatrick DR, Ching K, Iber J, Campagnoli R, Freeman CJ, Mishrik N, Liu HM, Pallansch MA, Kew OM. 2004. Multiplex PCR method for identifying recombinant vaccine-related polioviruses. J. Clin. Microbiol. 42:4313-4315. http://dx.doi.org/10.1128/JCM.42.9.4313-4315.2004. (Pubitemid 39296164)
13. Zhang Y, Zhu S, Yan D, Liu G, Bai R, Wang D, Chen L, Zhu H, An H, Kew O, Xu W. 2010. Natural type 3/type 2 intertypic vaccine-related poliovirus recombinants with the first crossover sites within the VP1 capsid coding region. PLoS One 5:e15300. http://dx.doi.org/10.1371/journal.pone.0015300.
14. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. 2011. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 28:2731-2739. http://dx.doi.org/10.1093/molbev/msr121.
15. Sun Q, Zhang Y, Zhu S, Tian H, Huang G, Cui H, Li X, Yan D, Zhu Z, Li J, Zheng P, Jiang H, Zhang B, Tan X, Zhu H, An H, Xu W. 2013. Transmission of human enterovirus 85 recombinants containing new unknown serotype HEV-B donor sequences in Xinjiang Uighur autonomous region, China. PLoS One 8:e55480. http://dx.doi.org/10.1371/journal.pone.0055480.
16. Drummond AJ, Rambaut A. 2007. BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol. Biol. 7:214. http://dx.doi.org/10.1186/1471-2148-7- 214.
17. Wang K, Zhang LB, Otten MW, Jr, Zhang XL, Yasuo C, Zhang RZ, Xu T, Liu X, Liu M, Li QL, Yu JJ, Wang Z. 1997. Status of the eradication of indigenous wild poliomyelitis in the People's Republic of China. J. Infect. Dis. 175(Suppl 1):S105-S112. http://dx.doi.org/10.1093/infdis/175.Supplement-1.S105. (Pubitemid 27053494)
18. World Health Organization. 2000. Certification of poliomyelitis eradication. WHO Western Pacific Region, October 2000. Wkly. Epidemiol. Rec. 75:399-400.
19. Luo HM, Zhang Y, Wang XQ, Yu WZ, Wen N, Yan DM, Wang HQ, Wushouer F, Wang HB, Xu AQ, Zheng JS, Li DX, Cui H, Wang JP, Zhu SL, Feng ZJ, Cui FQ, Ning J, Hao LX, Fan CX, Ning GJ, Yu HJ, Wang SW, Liu DW, Wang DY, Fu JP, Gou AL, Zhang GM, Huang GH, Chen YS, Mi SS, Liu YM, Yin DP, Zhu H, Fan XC, Li XL, Ji YX, Li KL, Tang HS, Xu WB, Wang Y, Yang WZ. 2013. Identification and control of a poliomyelitis outbreak in Xinjiang, China. N. Engl. J. Med. 369:1981-1990. http://dx.doi.org/10.1056/NEJMoa1303368.
20. Liu Y, Fang G, Du F, Tan ZY, Liu QL, Fang SM, Nian XH, Tong WB, Ma XZ, Chen N, Yang RP, Huang RN, Wang YM, Fu QP, Chen XC, Li YQ, Jing YL, Liu JJ. 2013. The epidemiologic investigation and analysis of circulating type 2 vaccine hypervariable poliovirus/vaccine-derived poliovirus event in Sichuan Province. Chin. J. Vaccines Immun. 19:407-412.
21. Macadam AJ, Pollard SR, Ferguson G, Skuce R, Wood D, Almond JW, Minor PD. 1993. Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates. Virology 192:18-26. http://dx.doi.org/10.1006/viro.1993. 1003.
22. Zhang Y, Wang H, Zhu S, Li Y, Song L, Liu Y, Liu G, Nishimura Y, Chen L, Yan D, Wang D, An H, Shimizu H, Xu A, Xu W. 2010. Characterization of a rare natural intertypic type 2/type 3 pentarecombinant vaccine-derived poliovirus isolated from a child with acute flaccid paralysis. J. Gen. Virol. 91:421-429. http://dx.doi.org/10.1099/vir.0.014258-0.
23. Yang CF, Naguib T, Yang SJ, Nasr E, Jorba J, Ahmed N, Campagnoli R, van der Avoort H, Shimizu H, Yoneyama T, Miyamura T, Pallansch M, Kew O. 2003. Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993. J. Virol. 77:8366-8377. http://dx.doi.org/10.1128/JVI.77.15.8366-8377. 2003. (Pubitemid 36871465)
24. Rousset D, Rakoto-Andrianarivelo M, Razafindratsimandresy R, Randriamanalina B, Guillot S, Balanant J, Mauclere P, Delpeyroux F. 2003. Recombinant vaccine-derived poliovirus in Madagascar. Emerg. Infect. Dis. 9:885-887. http://dx.doi.org/10.3201/eid0907.020692.
25. Minor PD, Ferguson M, Evans DM, Almond JW, Icenogle JP. 1986. Antigenic structure of polioviruses of serotypes 1, 2 and 3. J. Gen. Virol. 67:1283-1291. http://dx.doi.org/10.1099/0022-1317-67-7-1283.
26. Wiegers K, Dernick R. 1992. Molecular basis of antigenic structures of poliovirus: implications for their evolution during morphogenesis. J. Virol. 66:4597-4600.
27. Yan D, Li L, Zhu S, Zhang Y, An J, Wang D, Wen N, Jorba J, Liu W, Zhong G, Huang L, Kew O, Liang X, Xu W. 2010. Emergence and localized circulation of a vaccine-derived poliovirus in an isolated mountain community in Guangxi, China. J. Clin. Microbiol. 48:3274-3280. http://dx.doi.org/10.1128/JCM.00712-10.
28. Fine PE. 2000. Gaps in our knowledge about transmission of vaccine-derived polioviruses. Bull. World Health Organ. 78:358-359. (Pubitemid 30208327)
29. Rakoto-Andrianarivelo M, Gumede N, Jegouic S, Balanant J, Andriamamonjy SN, Rabemanantsoa S, Birmingham M, Randriamanalina B, Nkolomoni L, Venter M, Schoub BD, Delpeyroux F, Reynes JM. 2008. Reemergence of recombinant vaccine-derived poliovirus outbreak in Madagascar. J. Infect. Dis. 197:1427-1435. http://dx.doi.org/10.1086/587694. (Pubitemid 351706467)
30. Gumede N, Lentsoane O, Burns CC, Pallansch M, de Gourville E, Yogolelo R, Muyembe-Tamfum JJ, Puren A, Schoub BD, Venter M. 2013. Emergence of vaccine-derived polioviruses, Democratic Republic of Congo, 2004-2011. Emerg. Infect. Dis. 19:1583-1589. http://dx.doi.org/10.3201/eid1910.130028.
31. Wassilak S, Pate MA, Wannemuehler K, Jenks J, Burns C, Chenoweth P, Abanida EA, Adu F, Baba M, Gasasira A, Iber J, Mkanda P, Williams AJ, Shaw J, Pallansch M, Kew O. 2011. Outbreak of type 2 vaccine-derived poliovirus in Nigeria: emergence and widespread circulation in an underimmunized population. J. Infect. Dis. 203:898-909. http://dx.doi.org/10.1093/infdis/jiq140.
32. Minor PD, Evans DM, Ferguson M, Schild GC, Westrop G, Almond JW. 1985. Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3. J. Gen. Virol. 66:1159-1165. http://dx.doi.org/10.1099/ 0022-1317-66-5-1159. (Pubitemid 15067119)
33. Shimizu H, Thorley B, Paladin FJ, Brussen KA, Stambos V, Yuen L, Utama A, Tano Y, Arita M, Yoshida H, Yoneyama T, Benegas A, Roesel S, Pallansch M, Kew O, Miyamura T. 2004. Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001. J. Virol. 78:13512-13521. http://dx.doi.org/10.1128/JVI.78. 24.13512-13521.2004. (Pubitemid 39612751)
34. Kilpatrick DR, Yang CF, Ching K, Vincent A, Iber J, Campagnoli R, Mandelbaum M, De L, Yang SJ, Nix A, Kew OM. 2009. Rapid group-, serotype-, and vaccine strain-specific identification of poliovirus isolates by real-time reverse transcription-PCR using degenerate primers and probes containing deoxyinosine residues. J. Clin. Microbiol. 47:1939-1941. http://dx.doi.org/10. 1128/JCM.00702-09.
35. Liang X, Zhang Y, Xu W, Wen N, Zuo S, Lee LA, Yu J. 2006. An outbreak of poliomyelitis caused by type 1 vaccine-derived poliovirus in China. J. Infect. Dis. 194:545-551. http://dx.doi.org/10.1086/506359. (Pubitemid 44297837)
36. Kew O, Morris-Glasgow V, Landaverde M, Burns C, Shaw J, Garib Z, Andre J, Blackman E, Freeman CJ, Jorba J, Sutter R, Tambini G, Venczel L, Pedreira C, Laender F, Shimizu H, Yoneyama T, Miyamura T, van Der Avoort H, Oberste MS, Kilpatrick D, Cochi S, Pallansch M, de Quadros C. 2002. Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 296:356-359. http://dx.doi.org/10.1126/science.1068284. (Pubitemid 34303692)